Bastrop, TX, United States of America

Margaret Hanausek

This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Margaret Hanausek. Retrieved from https://idiyas.com/inventor/margaret-hanausek

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Margaret Hanausek

Introduction

Margaret Hanausek is a notable inventor based in Bastrop, Texas. She has made significant contributions to the field of medicine through her innovative research and development. Her work primarily focuses on the prevention and treatment of hypercholesterolemia and cellular hyperproliferation.

Latest Patents

Margaret holds 1 patent for her invention titled "Formula and method for the prevention and treatment of hypercholesterolemia and cellular hyperproliferation." This invention provides a formula and method that includes glucaric acid or a pharmaceutically acceptable salt thereof. It aims to significantly lower total and LDL levels of serum cholesterol while inhibiting cellular hyperproliferation when administered in therapeutic amounts.

Career Highlights

Margaret is affiliated with the University of Texas System, where she continues her research and development efforts. Her work has the potential to impact both human and animal health positively.

Collaborations

Some of her notable coworkers include Zbigniew Walaszek and Thomas J. Slaga. Their collaborative efforts contribute to the advancement of research in their respective fields.

Conclusion

Margaret Hanausek's innovative work in the prevention and treatment of hypercholesterolemia showcases her dedication to improving health outcomes. Her contributions to the field of medicine are commendable and reflect her commitment to scientific advancement.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…